DIRS.INFO The most relevant business & tech news

CHARLOTTE, N.C. (AP) — Florida State coach Mike Norvell said the possibility of leaving his unbeaten Seminoles out of the College Football Playoff shouldn't even be discussed. Florida State made things as difficult as possible on the CFP selection committee, using a dominant defensive performance to beat No. In all likelihood, Rodemaker would be ready to play should Florida State make the playoff, but even he has only started two games. Florida State also had 14 tackles for loss and 10 pass breakups. “I feel like we go out there and play for each other and we are a close-knit team,” Toafili said.

Persons: CHARLOTTE, Mike Norvell, Brock Glenn, “, ” Norvell, ” Lawrance Toafili, Glenn, Jordan Travis, Tate Rodemaker, Travis, Alex Mastromanno, Tatum Bethune, Jack Plummer’s, Plummer, Jeff Brohm, Ryan Fitzgerald, Braden Fiske, Fitzgerald, Fiske, Toafili, Norvell, ” Toafili, haven't, Rodemaker, ___ Organizations: Florida State, Seminoles, College, CFP, Louisville, Atlantic Coast Conference, Alabama, Southeastern Conference, Texas, Heisman, ACC, Cardinals, AP Locations: N.C, Florida, Georgia, Louisville

☆ Insurers and drug-industry middlemen are cashing in on the weight-loss drug frenzy
▼ + stars: | 2023-09-28 | by ( ) www.businessinsider.com time to read: +5 min

Insurers and the drug-industry middlemen they own stand to earn more as healthcare spending increases. AdvertisementAdvertisementFor US health insurers, explosive demand for new weight-loss drugs likely means bigger profits. Insurers and the drug-industry middlemen they own stand to earn more as weight-loss drugs drive up healthcare spending, BofA analysts wrote. Meanwhile, if the drugs help people live longer, insurers could earn more from higher enrollment in their health plans. As weight-loss drugs drive up healthcare spending, insurers will make more moneyWeight-loss drugs, which can cost around $1,000 a month, are driving up healthcare spending.

Persons: Li Ran, Brian Evanko, Evernorth Organizations: Trilliant Health, Bank of America Global Research, Getty, Cigna, CVS Health, UnitedHealth Group, CVS, Kaiser Family Foundation Locations: Xinhua, GLP

☆ Earthquake of magnitude 7.0 strikes Bali Sea, Indonesia –EMSC
▼ + stars: | 2023-08-28 | by ( ) www.reuters.com time to read: +1 min

JAKARTA, Aug 29 (Reuters) - A strong earthquake of 7.0 magnitude struck deep in the sea north of Bali and Lombok islands in Indonesia early on Tuesday, the European-Mediterranean Seismological Centre (EMSC) said, sending residents running out of buildings. The quake's epicentre was 203 km (126 miles) north of Mataram, Indonesia, and very deep at 516 km below the Earth's surface, EMSC said. Indonesian and U.S. geological agencies pegged the magnitude at 7.1, with no threat of a tsunami. Guests at Bali's Mercure Kuta Bali ran out of their rooms after feeling the tremor for a few seconds, hotel manager Suadi told Reuters by phone. "The quake is deep so it should not be destructive," BNPB spokesperson Abdul Muhari said.

Persons: EMSC, Bali, Suadi, BNPB, Abdul Muhari, Ananda Teresia, Kanjyik Ghosh, Gayatri Suroyo, Sandra Maler, Stephen Coates Organizations: Seismological, Mercure, Reuters, Thomson Locations: JAKARTA, Bali, Lombok, Indonesia, European, Mataram, Indonesian, Jakarta, Bengaluru

☆ A $7 billion startup wanted to build patient-friendly healthcare. Its bet on buzzy weight-loss drugs is testing that vision.
▼ + stars: | 2023-06-29 | by ( Blake Dodge | Rebecca Torrence | ) www.businessinsider.com time to read: +12 min

Patient complaints go beyond the Wegovy shortageKaitlyn's complaints echo an array of issues faced by other Ro patients seeking weight-loss drugs. The patients Insider interviewed asked to be identified by their first names to protect their privacy. In this chat log, a Ro weight-loss patient sends messages to the startup asking to cancel the program. Reitano told Insider that around 90% of Ro patients got a response within 24 hours. "Until these DTC companies generally start getting into the muck of healthcare, they're not going to have a material impact," Parker told Insider.

Persons: Ro, Zachariah Reitano, Reitano, Li Ran, Robyn Phelps, Kaitlyn, She'd, didn't, she's, couldn't, Max Kerwick, drugstores, Max, Ro's, aren't, hasn't, Florian Gaertner, it's, TJ Parker, they're, Parker Organizations: New York, Getty, Better Business Bureau, Nordisk, Better Business, CareMetx, Ro, TechCrunch Locations: Xinhua, New York, New York City

☆ Inside your company's struggle over whether to pay for hot, new weight-loss drugs
▼ + stars: | 2023-06-20 | by ( ) www.businessinsider.com time to read: +10 min

Americans are clamoring for new weight-loss drugs, but companies aren't rushing to pay for them. At most, half of US employers help pay for weight-loss drugs for their workers, according to several estimates. "The drug companies, providers, and patient groups are insisting that weight loss will improve health and therefore offset these massive costs. Known as GLP-1 agonists, the drugs — Wegovy and Ozempic from Novo Nordisk and Eli Lilly's Mounjaro — mimic a gut hormone known as glucagon-like peptide 1, helping to suppress people's appetites and slow their digestion. Brent Eberle, the chief pharmacy officer at Navitus, said very few of the employers that worked with his pharmacy-benefit manager paid for weight-loss drugs.

Persons: that's, They're, AJ Loiacono, Li Ran, James Gelfand, Eli Lilly's, Ozempic, drugmakers, Brent Eberle, Navitus, Eberle, it's, Pat Gleason, Gleason, Wegovy, Eli Lilly, Lilly, Florian Gaertner, Loiacono Organizations: Morning, Novo Nordisk, Getty, Workers, Drugmakers, Therapeutics, Blue, Mayo Clinic, and Drug Administration, Capital Locations: Novo, Xinhua

☆ People probably have to be on Ozempic forever. But no one is ready for the bill.
▼ + stars: | 2023-06-02 | by ( Hilary Brueck | ) www.businessinsider.com time to read: +9 min

But she knows — from experience — that probably won't be possible if she has to stop taking the drug once her manufacturer-issued coupons expire. But the injections don't work once people stop taking them. Li Ran/Xinhua via Getty ImagesMany health insurers and employers have long declined to pay for weight-loss drugs. He has resumed taking weight-loss medication but said he hoped to go down to a lower dose. Want to tell us about your experience with health insurance and weight-loss drugs?

Persons: Tara Rothenhoefer, Rothenhoefer, Eli Lilly's, Insider's Gabby Landsverk, —, Wegovy, Rothenhoefer Novo, we're, Dr, Martin Lange, Novo, Eli Lilly, Li Ran, Sean Duffy, Omada, Duffy, hungrier, Nisha Patel, it's, " Lange, Bill, Gabby Landsverk, Shelby Livingston, Hilary Brueck Organizations: Rothenhoefer Novo Nordisk, Novo Nordisk, Getty, National Library of Medicine Locations: San Francisco, Novo, Xinhua, slivingston

☆ Medicare is prohibited from paying for weight-loss drugs. These are the 3 potential ways to change that.
▼ + stars: | 2023-05-22 | by ( ) www.businessinsider.com time to read: +6 min

There are three routes lawmakers and regulators could use to add coverage for weight-loss drugs. Older Americans hoping to get their hands on powerful weight-loss drugs such as Ozempic and Wegovy may find it impossible to access them. Should Medicare cover weight loss medication, it could also unlock access for people who have private coverage. "A decision by Medicare to cover weight-loss drugs would put pressure on employers and other private insurers to cover weight-loss drugs too," said Tricia Neuman, a senior vice president at KFF who co-authored a recent brief on the subject. There are three potential strategies that could be used to expand Medicare coverage to weight-loss drugs.

☆ Schneider Electric Expands North American Manufacturing
▼ + stars: | 2023-05-15 | by ( Liz Young | ) www.wsj.com time to read: 1 min

Schneider Electric is moving some manufacturing to North America from Asia and Europe. Here, a Schneider facility in Tianjin, China. Photo: Li Ran/Zuma PressSchneider Electric , one of the world’s largest makers of electrical and automation products, is shifting some manufacturing closer to the U.S. from factories in Asia and Europe as it pushes ahead with a regional manufacturing strategy. The moves are meant to position the France-based company, which makes goods such as light switches, electric-vehicle chargers, home-automation systems and data-center equipment, to meet growing demand in North America and to compete for federal subsidies aimed at expanding manufacturing in the U.S.

Search resuls for: "Li Ran"

8 mentions found